Characterization Of Cumulative Joint Damage Patterns In Patients With Rheumatoid Arthritis: A Clinical, Serological, And Gene Polymorphism Perspective

Objective. To characterize cumulative joint damage (CJD) patterns in rheumatoid arthritis (RA) and determine their associations with demographic/clinical features and HLA-DRB1 gene polymorphism. Methods. Hand and foot radiographs were obtained from 404 patients with RA. CJD patterns were determined by 3 derivations from Sharp/van der Heijde scores, obtained by the mathematical division of scores for hands/feet (Sharp-h/f score), fingers/wrists (Sharp-f/w score), and erosion/space narrowing (Sharp-e/sn score), respectively. DNA and serum were obtained for determination of HLA-DRB1 polymorphism, rheumatoid factor (RF), and anticitrullinated protein antibodies (ACPA). Results. Patients with wrist-dominant CJD pattern were more likely to have severe RA than those with finger-dominant pattern (68.4% vs 46.0%; p = 0.036) as were those with foot-dominant vs hand-dominant CJD pattern (76.5% vs 56.4%; p = 0.044). HLA-DRB1 shared epitope (SE) alleles were associated with erosion-dominant CJD pattern (p = 0.021). Patients with erosion-dominant CJD pattern had higher levels of RF and ACPA than those with space-narrowing-dominant CJD pattern (median RF 71.35 U/ml vs 22.05 U/ml, respectively; p = 0.003; median ACPA 187.9 U/ml vs 143.2 U/ml, respectively; p < 0.001). The majority of triple-positive patients (SE+, RF+, ACPA+) had erosion-dominant CJD pattern (62.3%) while the majority of triple-negative patients (SE-, FR-, ACPA-) had space narrowing-dominant CJD pattern (75%; p = 0.017). ACPA was associated with HLA-DRB1 SE alleles (p < 0.05). Patients with foot-dominant CJD pattern were taller than those with hand-dominant CJD pattern (p = 0.002); those with erosion-dominant CJD pattern had higher weight and body mass index than those with space narrowing-dominant CJD pattern (p = 0.014, p = 0.001). Conclusion. CJD patterns were associated with disease severity, HLA-DRB1 SE status, presence and titer of ACPA and RF, and morphometric features.423405412Combe, B., Can the outcome of rheumatoid arthritis be predicted at the onset of the disease? (1995) Rev Rhum Ed Fr, 61, pp. 477-479Van Der Heijde, D.M., How to read radiographs according to the Sharp-van der Heijde method (2000) J Rheumatol, 27, pp. 261-263Hulsmans, H.M., Jacobs, J.W., Van Der Heijde, D.M., Van Albada-Kuipers, G.A., Schenk, Y., Bijlsma, J.W., The course of radiologic damage during the first six years of rheumatoid arthritis (2000) Arthritis Rheum, 43, pp. 1927-1940Smolen, J.S., Van Der Heijde, D.M., Aletaha, D., Xu, S., Han, J., Baker, D., Progression of radiographic joint damage in rheumatoid arthritis: Independence of erosions and joint space narrowing (2009) Ann Rheum Dis, 68, pp. 1535-1540Landewé, R.B., Strand, V., Conaghan, P.G., Van Der Heijde, D., Damage and progression on radiographs in individual joints: Data from pivotal randomized controlled trials (2011) J Rheumatol, 38, pp. 2018-2022Dirven, L., Van Den Broek, M., Kroon, H.M., Grillet, B.A., Han, K.H., Kerstens, P.J., Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints (2012) Rheumatology, 51, pp. 2262-2268Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis (1988) Arthritis Rheum, 31, pp. 315-324Ferraz, M.B., Oliveira, L.M., Araujo, P.M., Atra, E., Tugwell, P., Crosscultural reliability of the physical ability dimension of the health assessment questionnaire (1990) J Rheumatol, 17, pp. 813-817Bértolo, M., Costallat, L.T., Persoli, L.B., Costa, F.F., HLA-DRB1 alleles and prognosis of Brazilian patients with rheumatoid arthritis (2001) Rev Bras Reumatol, 41, pp. 151-156Louzada-Júnior, P., Freitas, M.V., Oliveira, R.D., Deghaide, N.H., Conde, R.A., Bertolo, M.B., A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrullinated peptide antibodies (2008) Braz J Med Biol Res, 41, pp. 493-499Usnayo, M.J., Andrade, L.E., Alarcon, R.T., Oliveira, J.C., Silva, G.M., Bendet, I., Study of the frequency of HLA-DRB1 alleles in Brazilian patients with rheumatoid arthritis (2011) Rev Bras Reumatol, 51, pp. 474-483Kaltenhäuser, S., Wagner, U., Schuster, E., Wassmuth, R., Arnold, S., Seidel, W., Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity (2001) J Rheumatol, 28, pp. 735-744Khani-Hanjani, A., Lacaille, D., Horne, C., Chalmers, A., Hoar, D.I., Balshaw, R., Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis (2002) J Rheumatol, 29, pp. 1358-1365Janssens, A.C., Steyerberg, E.W., Jiang, Y., Habbema, J.D., Van Duijn, C.M., Criswell, L.A., Value of the HLA-DRB1 shared epitope for predicting radiographic damage in rheumatoid arthritis depends on the individual patient risk profile (2006) J Rheumatol, 33, pp. 2383-2389Reneses, S., González-Escribano, M.F., Fernández-Suárez, A., Pestana, L., Davila, B., Wichmann, I., The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis (2009) J Rheumatol, 36, pp. 1143-1149Markatseli, T.E., Voulgari, P.V., Alamanos, Y., Drosos, A.A., Prognostic factors of radiological damage in rheumatoid arthritis: A 10-year retrospective study (2011) J Rheumatol, 38, pp. 44-52Symmons, D.P., Bankhead, C.R., Harrison, B.J., Brennan, P., Barrett, E.M., Scott, D.G., Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: Results from a primary care-based incident case-control study in Norfolk, England (1997) Arthritis Rheum, 40, pp. 1955-1961Gremese, E., Ferraccioli, G., The metabolic syndrome: The crossroads between rheumatoid arthritis and cardiovascular risk (2011) Autoimmun Rev, 10, pp. 582-589Kroot, E.J., De Jong, B.A., Van Leeuwen, M.A., Swinkels, H., Van Den Hoogen, F.H., Van'T Hof, M., The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis (2000) Arthritis Rheum, 43, pp. 1831-1835Meyer, O., Labarre, C., Dougados, M., Goupille, P., Cantagrel, A., Dubois, A., Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage (2003) Ann Rheum Dis, 62, pp. 120-126Kastbom, A., Strandberg, G., Lindroos, A., Skogh, T., Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project) (2004) Ann Rheum Dis, 63, pp. 1085-1089Lindqvist, E., Eberhardt, K., Bendtzen, K., Heinegård, D., Saxne, T., Prognostic laboratory markers of joint damage in rheumatoid arthritis (2005) Ann Rheum Dis, 64, pp. 196-201Fathi, N.A., Ezz-Eldin, A.M., Mosad, E., Bakry, R.M., Hamed, H.B., Ahmed, S., Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis (2008) Int Arch Med, 22, pp. 20-27Gorman, J.D., Lum, R.F., Chen, J.J., Suarez-Almazor, M.E., Thomson, G., Criswell, L.A., Impact of shared epitope genotype and ethnicity on erosive disease: A meta-analysis of 3,240 rheumatoid arthritis patients (2004) Arthritis Rheum, 50, pp. 400-412Valenzuela-Castaño, A., García-López, A., Pérez-Vilches, D., Rodriguez-Pérez, R., Gonzalez-Escribano, M.F., Núñez-Roldán, A., The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study (2000) J Rheumatol, 27, pp. 571-57